To investigate whether c-Myc has a prognostic value for cervical cancer, we assessed the prognostic value of c-Myc expression through two publicly available clinical tools, as follows: Kaplan–Meier Plotter1 and OncoLnc.2 Progression-free survival Kaplan–Meier analysis of these two databases suggested that high expression of c-Myc was significantly correlated with poor overall survival probability, whereas low expression was significantly correlated with good prognosis (Figures 4C,D). The gene discussed is MYC; the disease is cervical carcinoma.